Literature DB >> 29535188

Dystrophin's central domain forms a complex filament that becomes disorganized by in-frame deletions.

Olivier Delalande1, Anne-Elisabeth Molza2, Raphael Dos Santos Morais2,3,4, Angélique Chéron2, Émeline Pollet2, Céline Raguenes-Nicol2, Christophe Tascon2, Emmanuel Giudice2, Marine Guilbaud5, Aurélie Nicolas2, Arnaud Bondon2,6, France Leturcq5,7, Nicolas Férey8, Marc Baaden9, Javier Perez3, Pierre Roblin3,10, France Piétri-Rouxel5, Jean-François Hubert2, Mirjam Czjzek11,12, Elisabeth Le Rumeur2.   

Abstract

Dystrophin, encoded by the DMD gene, is critical for maintaining plasma membrane integrity during muscle contraction events. Mutations in the DMD gene disrupting the reading frame prevent dystrophin production and result in severe Duchenne muscular dystrophy (DMD); in-frame internal deletions allow production of partly functional internally deleted dystrophin and result in less severe Becker muscular dystrophy (BMD). Many known BMD deletions occur in dystrophin's central domain, generally considered to be a monotonous rod-shaped domain based on the knowledge of spectrin family proteins. However, the effects caused by these deletions, ranging from asymptomatic to severe BMD, argue against the central domain serving only as a featureless scaffold. We undertook structural studies combining small-angle X-ray scattering and molecular modeling in an effort to uncover the structure of the central domain, as dystrophin has been refractory to characterization. We show that this domain appears to be a tortuous and complex filament that is profoundly disorganized by the most severe BMD deletion (loss of exons 45-47). Despite the preservation of large parts of the binding site for neuronal nitric oxide synthase (nNOS) in this deletion, computational approaches failed to recreate the association of dystrophin with nNOS. This observation is in agreement with a strong decrease of nNOS immunolocalization in muscle biopsies, a parameter related to the severity of BMD phenotypes. The structural description of the whole dystrophin central domain we present here is a first necessary step to improve the design of microdystrophin constructs toward the goal of a successful gene therapy for DMD.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Becker muscular dystrophy; dystrophin; dystrophin central domain; molecular docking; multiresolution modeling; muscular dystrophy; nitric oxide synthase; small-angle X-ray scattering (SAXS)

Mesh:

Substances:

Year:  2018        PMID: 29535188      PMCID: PMC5936807          DOI: 10.1074/jbc.M117.809798

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Structures of two repeats of spectrin suggest models of flexibility.

Authors:  V L Grum; D Li; R I MacDonald; A Mondragón
Journal:  Cell       Date:  1999-08-20       Impact factor: 41.582

Review 2.  Advances in X-ray scattering: from solution SAXS to achievements with coherent beams.

Authors:  Javier Pérez; Yoshinori Nishino
Journal:  Curr Opin Struct Biol       Date:  2012-09-03       Impact factor: 6.809

3.  Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.

Authors:  Christophe Béroud; Sylvie Tuffery-Giraud; Masafumi Matsuo; Dalil Hamroun; Véronique Humbertclaude; Nicole Monnier; Marie-Pierre Moizard; Marie-Antoinette Voelckel; Laurence Michel Calemard; Pierre Boisseau; Martine Blayau; Christophe Philippe; Mireille Cossée; Michel Pagès; François Rivier; Olivier Danos; Luis Garcia; Mireille Claustres
Journal:  Hum Mutat       Date:  2007-02       Impact factor: 4.878

4.  Characterization of Intersubunit Communication in the Virginiamycin trans-Acyl Transferase Polyketide Synthase.

Authors:  Jonathan Dorival; Thibault Annaval; Fanny Risser; Sabrina Collin; Pierre Roblin; Christophe Jacob; Arnaud Gruez; Benjamin Chagot; Kira J Weissman
Journal:  J Am Chem Soc       Date:  2016-03-16       Impact factor: 15.419

5.  Dystrophin: the protein product of the Duchenne muscular dystrophy locus.

Authors:  E P Hoffman; R H Brown; L M Kunkel
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

6.  SASBDB, a repository for biological small-angle scattering data.

Authors:  Erica Valentini; Alexey G Kikhney; Gianpietro Previtali; Cy M Jeffries; Dmitri I Svergun
Journal:  Nucleic Acids Res       Date:  2014-10-28       Impact factor: 16.971

7.  The 8th and 9th tandem spectrin-like repeats of utrophin cooperatively form a functional unit to interact with polarity-regulating kinase PAR-1b.

Authors:  Kazunari Yamashita; Atsushi Suzuki; Yoshinori Satoh; Mariko Ide; Yoshiko Amano; Maki Masuda-Hirata; Yukiko K Hayashi; Keisuke Hamada; Kazuhiro Ogata; Shigeo Ohno
Journal:  Biochem Biophys Res Commun       Date:  2009-11-27       Impact factor: 3.575

8.  The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein.

Authors:  M Koenig; A P Monaco; L M Kunkel
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

Review 9.  The cell biology of disease: cellular and molecular mechanisms underlying muscular dystrophy.

Authors:  Fedik Rahimov; Louis M Kunkel
Journal:  J Cell Biol       Date:  2013-05-13       Impact factor: 10.539

10.  Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division.

Authors:  Nicolas A Dumont; Yu Xin Wang; Julia von Maltzahn; Alessandra Pasut; C Florian Bentzinger; Caroline E Brun; Michael A Rudnicki
Journal:  Nat Med       Date:  2015-11-16       Impact factor: 53.440

View more
  5 in total

1.  Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy.

Authors:  Kay E Davies; Simon Guiraud
Journal:  Mol Ther       Date:  2019-02-12       Impact factor: 11.454

2.  Human Dystrophin Structural Changes upon Binding to Anionic Membrane Lipids.

Authors:  Raphael Dos Santos Morais; Olivier Delalande; Javier Pérez; Dominique Mias-Lucquin; Mélanie Lagarrigue; Anne Martel; Anne-Elisabeth Molza; Angélique Chéron; Céline Raguénès-Nicol; Thomas Chenuel; Arnaud Bondon; Marie-Sousai Appavou; Elisabeth Le Rumeur; Sophie Combet; Jean-François Hubert
Journal:  Biophys J       Date:  2018-08-17       Impact factor: 4.033

Review 3.  What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy?

Authors:  Dominic J Wells
Journal:  J Muscle Res Cell Motil       Date:  2019-07-09       Impact factor: 2.698

4.  Fine mapping of hydrophobic contacts reassesses the organization of the first three dystrophin coiled-coil repeats.

Authors:  Dominique Mias-Lucquin; Angélique Chéron; Elisabeth Le Rumeur; Jean-François Hubert; Olivier Delalande
Journal:  Protein Sci       Date:  2019-01-14       Impact factor: 6.725

5.  Dystrophin R16/17-syntrophin PDZ fusion protein restores sarcolemmal nNOSμ.

Authors:  Aman Patel; Junling Zhao; Yongping Yue; Keqing Zhang; Dongsheng Duan; Yi Lai
Journal:  Skelet Muscle       Date:  2018-11-22       Impact factor: 4.912

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.